4 New Research Grants to Promote Study of Tumor Treating Fields as Cancer Therapy

4 New Research Grants to Promote Study of Tumor Treating Fields as Cancer Therapy
In a collaborative effort to support and advance innovative research on Tumor Treating Fields (TTFields) — a therapy that uses electric fields to promote cell death — the oncology company Novocure and the American Association for Cancer Research (AACR) will award four inaugural grants. A recent Phase 2 pilot clinical trial (NCT02244502) evaluated the therapy and showed that adding it to Taxol (paclitaxel) significantly slowed disease progression in recurrent ovarian cancer patients. Grant categories include the two-year, $250,000 AACR-Novocure Tumor Treating Fields Research Grant; the three-year, $225,000 AACR-Novocure Career Development Award For Tumor Treating Fields Research Grant; the two-year, $120,000 AACR-Novocure Tumor Treating Fields Research Fellowship, and the one-year, $25,000 AACR-Novocure Discovery Grant. The grant terms begin July 1. Proposals must emphasize preclinical applications of TTF in cancer, and may be basic or translational. Applicants must have a doctoral degree in a related field, and not currently be a candidate for a second docto
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *